Sandbox

• The following are discussed in more detail in other sections of the labeling:

• Use in elderly patients with dementia-related psychosis
• Suicidal thoughts and behaviors in adolescents and young adults
• Neuroleptic malignant syndrome (NMS)
• Tardive dyskinesia
• Metabolic changes
• Orthostatic hypotension
• Leukopenia, neutropenia, and agranulocytosis
• Seizures/convulsions
• Potential for cognitive and motor impairmen
• Body temperature regulation
• Suicide
• Dysphagia
• Use in patients with concomitant illness